NATCO PHARMA Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA Quarterly Results    (NTPH)

Here are the latest quarterly results of NATCO PHARMA. For more details, see the NATCO PHARMA financial fact sheet and NATCO PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

NATCO PHARMA Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
3
Sep-21
*
3
Dec-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m4,5485,6348,0223,5523,3134,1033,7725,605 
Other income Rs m224187257308284170380302 
Turnover Rs m4,7725,8218,2793,8603,5974,2734,1525,907 
Expenses Rs m3,2653,9235,2582,7272,5513,0053,0674,587 
Gross profit Rs m1,2831,7112,7648257621,0987051,018 
Depreciation Rs m305280287298304338347360 
Interest Rs m3537273435204050 
Profit before tax Rs m1,1671,5812,707801707910698910 
Tax Rs m23536066816717716047106 
Profit after tax Rs m9321,2212,039634530750651804 
Gross profit margin %28.230.434.523.223.026.818.718.2 
Effective tax rate %20.122.824.720.825.017.66.711.6 
Net profit margin %20.521.725.417.816.018.317.314.3 
Diluted EPS Rs 5.1 6.7 11.2 3.5 2.9 4.1 3.6 4.4  
Diluted EPS (TTM) Rs 25.1 24.0 28.7 26.4 24.2 21.7 14.1 15.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Today's Market

Sensex Rallies 632 Points, Nifty Ends Above 16,350; Banking & IT Stocks Witness Buying(Closing)

Indian share markets rose today as easing bets about aggressive interest rate hikes by central banks lifted sentiment.

Views on news

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


May 27, 2022 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NATCO PHARMA

NATCO PHARMA - ACTAVIS COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS